These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7923826)

  • 41. [Thyrotoxic periodic paralysis and Graves' disease. Description of an HLA-CW7-positive case].
    Pandolfi C; Pellegrini L; Vitelli E; Sbalzarini G
    Minerva Endocrinol; 1991; 16(3):153-5. PubMed ID: 1666906
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thyrotoxic periodic paralysis: a peculiar case with unusual dystonic behavior and variable relations of paralysis to serum potassium levels.
    Kusakabe T; Yoshida M; Nishikawa M
    J Clin Endocrinol Metab; 1976 Oct; 43(4):730-40. PubMed ID: 977720
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and metabolic features of thyrotoxic periodic paralysis in 24 episodes.
    Manoukian MA; Foote JA; Crapo LM
    Arch Intern Med; 1999 Mar; 159(6):601-6. PubMed ID: 10090117
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Muscle membrane excitability after exercise in thyrotoxic periodic paralysis and thyrotoxicosis without periodic paralysis.
    Arimura K; Arimura Y; Ng AR; Sakoda S; Higuchi I
    Muscle Nerve; 2007 Dec; 36(6):784-8. PubMed ID: 17722048
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Thyrotoxic hypokalemic periodic paralysis: 18 cases with different forms of thyrotoxicosis].
    Piraino Neuenschwander P; Pumarino Carte H; Bidegain González F; Zura Jiménez ML; Ferreiro Merino F
    Rev Clin Esp; 1995 May; 195(5):294-7. PubMed ID: 7617935
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thyrotoxic periodic paralysis terminated with intravenous propranolol.
    Shayne P; Hart A
    Ann Emerg Med; 1994 Oct; 24(4):736-40. PubMed ID: 8092604
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug-induced thyrotoxic periodic paralysis.
    Kane MP; Busch RS
    Ann Pharmacother; 2006 Apr; 40(4):778-81. PubMed ID: 16537816
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Platelet membrane fluidity and Na+/K+ ATPase activity in acute stroke.
    Nanetti L; Vignini A; Raffaelli F; Moroni C; Silvestrini M; Provinciali L; Mazzanti L
    Brain Res; 2008 Apr; 1205():21-6. PubMed ID: 18343354
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A 23Na-NMR study on cation transport systems in a patient with hypokalemic periodic paralysis.
    Cacciafesta M; Cammarella I; Ruggeri R; Germani MA; Soldo AR; Musca A
    Recenti Prog Med; 1993 May; 84(5):350-6. PubMed ID: 8390085
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of growth hormone and insulin-like growth factor I on salinity tolerance and gill Na+, K+-ATPase in Atlantic salmon (Salmo salar): interaction with cortisol.
    McCormick SD
    Gen Comp Endocrinol; 1996 Jan; 101(1):3-11. PubMed ID: 8713639
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thyrotoxic periodic paralysis in pregnancy with impaired glucose tolerance: a case report and discussion of management issues.
    Donovan L; Parkins VM; Mahalingham A
    Thyroid; 2007 Jun; 17(6):579-83. PubMed ID: 17614780
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thyrotoxic Periodic Paralysis: An Unusual Cause of Quadriparesis.
    Kaeley N; Ameena M S S; S S; Gangdev AM; Rajta M
    Cureus; 2022 Sep; 14(9):e29355. PubMed ID: 36284822
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Rare Case of Thyrotoxic Periodic Paralysis After Epidural Steroid Injection: A Case Report and Literature Review.
    Affram KO; Reddy TL; Osei KM
    Am J Case Rep; 2018 Dec; 19():1453-1458. PubMed ID: 30531678
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel lincRNA Susceptibility Gene and Its Role in Etiopathogenesis of Thyrotoxic Periodic Paralysis.
    Melo MCC; de Souza JS; Kizys MML; Vidi AC; Dorta HS; Kunii IS; Giannocco G; Carvalheira G; Dias-da-Silva MR
    J Endocr Soc; 2017 Jul; 1(7):809-815. PubMed ID: 29264532
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acute hypercapnic respiratory failure due to thyrotoxic periodic paralysis.
    Liu YC; Tsai WS; Chau T; Lin SH
    Am J Med Sci; 2004 May; 327(5):264-7. PubMed ID: 15166747
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Episodes of paralysis in Chinese men with thyrotoxic periodic paralysis are associated with elevated serum testosterone.
    Yao Y; Fan L; Zhang X; Xiao Z; Long Y; Tian H
    Thyroid; 2013 Apr; 23(4):420-7. PubMed ID: 23405854
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autonomously functioning thyroid nodule associated with thyrotoxic periodic paralysis.
    Ozaki H; Mori K; Nakagawa Y; Hoshikawa S; Ito S; Yoshida K
    Endocr J; 2008 Mar; 55(1):113-9. PubMed ID: 18202530
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Association of HLA antigens with thyrotoxic periodic paralysis].
    Liu WH; Liu CD; Zhang JY
    Zhonghua Nei Ke Za Zhi; 1991 Jul; 30(7):395-8, 454. PubMed ID: 1752149
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Therapeutic analysis in Chinese patients with thyrotoxic periodic paralysis over 6 years.
    Shiang JC; Cheng CJ; Tsai MK; Hung YJ; Hsu YJ; Yang SS; Chu SJ; Lin SH
    Eur J Endocrinol; 2009 Dec; 161(6):911-6. PubMed ID: 19755408
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.